Icahn School of Medicine at Mount Sinai
New York, 10029, United States
Location status: Recruiting
Location contact
Uraina Clark, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT05675332
The purpose of this study is to investigate the behavioral and neural correlates of stress exposure. Results from this study will enrich the understanding of how sociocultural, behavioral, and neural factors combine to influence alcohol use.
Interested in participating?
Request Info21 year–35 year
All sexes
Interventional
Not applicable
New York, 10029, United States
Location status: Recruiting
Uraina Clark, PhD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Brief behavioral intervention is absent of stressors.
Time frame: Baseline
Blood oxygen-level dependent (BOLD) signal in brain regions of interest (ROI) measured using fMRI
Time frame: Baseline
Resting-state functional connectivity - brain activity measured using fMRI
Contact information is provided by the study sponsor or research team.
Icahn School of Medicine at Mount Sinai
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03294460
Alcohol Drinking, Behavior
Bethesda, Maryland, United States
View Trial DetailsNCT05729256
Acquired Immunodeficiency Syndrome, Alcohol Drinking
Boston, Massachusetts, United States
View Trial DetailsNCT06158880
Alcohol Drinking, Behavior
Phoenix, Arizona, United States
View Trial DetailsNCT02108054
Addiction, Alcohol Dependence
Bethesda, Maryland, United States
View Trial Details